Pediatric Blood & Cancer · 2015 · 114 citations · 80 references
MedicineOncologyPediatricsCancer ControlPediatric HematologyPediatric OncologyCancer StagingMalignant NeoplasmsBaseline Risk StratificationClinical Guidelines AdherenceClinical Practice Guidelines ImplementationNeuroblastoma Biology
Neuroblastoma is the most common extracranial solid tumor in childhood in high-income countries (HIC), where consistent treatment approaches based on clinical and tumor biological risk stratification have steadily improved outcomes. However, in low- and middle- income countries (LMIC), suboptimal diagnosis, risk stratification, and treatment may occur due to limited resources and unavailable infrastructure. The clinical practice guidelines outlined in this manuscript are based on current published evidence and expert opinions. Standard risk stratification and treatment explicitly adapted to graduated resource settings can improve outcomes for children with neuroblastoma by reducing preventable toxic death and relapse.
80
Katherine K. Matthay, Judith G. Villablanca, Robert C. Seeger et al. · New England Journal of Medicine · 1999 · 1.9K citations · Full text
Medicine, Oncology, Pharmacology +7
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak et al. · New England Journal of Medicine · 2010 · 1.8K citations · Full text
Medicine, Immunology, Oncology +14
The International Neuroblastoma Pathology Classification (the Shimada system)
Hiroyuki Shimada, Inge M. Ambros, Louis P. Dehner et al. · Cancer · 1999 · 1K citations